A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation
J. Clin. Invest. Shao H. Yang, et al. 116:2115
doi:10.1172/JCI28968 [Go to this article.]

Problems with a PDF?